PL370415A1 - Związki hamujące wydzielanie cytokin zapalnych - Google Patents

Związki hamujące wydzielanie cytokin zapalnych

Info

Publication number
PL370415A1
PL370415A1 PL02370415A PL37041502A PL370415A1 PL 370415 A1 PL370415 A1 PL 370415A1 PL 02370415 A PL02370415 A PL 02370415A PL 37041502 A PL37041502 A PL 37041502A PL 370415 A1 PL370415 A1 PL 370415A1
Authority
PL
Poland
Prior art keywords
substituted
compounds
inflammatory cytokines
release
unsubstituted
Prior art date
Application number
PL02370415A
Other languages
English (en)
Inventor
Michael Phillip Clark
Matthew John Laufersweiler
Jane Far-Jine Djung
Biswanath De
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of PL370415A1 publication Critical patent/PL370415A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL02370415A 2001-09-20 2002-09-20 Związki hamujące wydzielanie cytokin zapalnych PL370415A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32362501P 2001-09-20 2001-09-20

Publications (1)

Publication Number Publication Date
PL370415A1 true PL370415A1 (pl) 2005-05-30

Family

ID=23259997

Family Applications (3)

Application Number Title Priority Date Filing Date
PL02370362A PL370362A1 (pl) 2001-09-20 2002-09-20 6,7-Dihydro-5H-pirazolo[1,2-a]pirazol-1-ony regulujące cytokiny zapalne
PL02370415A PL370415A1 (pl) 2001-09-20 2002-09-20 Związki hamujące wydzielanie cytokin zapalnych
PL02370351A PL370351A1 (pl) 2001-09-20 2002-09-20 Spirocykliczne 6,7-dihydro-5H-pirazolo[1,2-a]pirazol-1-ony regulujące cytokiny zapalne

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL02370362A PL370362A1 (pl) 2001-09-20 2002-09-20 6,7-Dihydro-5H-pirazolo[1,2-a]pirazol-1-ony regulujące cytokiny zapalne

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL02370351A PL370351A1 (pl) 2001-09-20 2002-09-20 Spirocykliczne 6,7-dihydro-5H-pirazolo[1,2-a]pirazol-1-ony regulujące cytokiny zapalne

Country Status (32)

Country Link
US (2) US6821971B2 (pl)
EP (3) EP1427727B1 (pl)
JP (3) JP2005504082A (pl)
KR (4) KR20060036125A (pl)
CN (3) CN1257905C (pl)
AR (3) AR037145A1 (pl)
AT (3) ATE287887T1 (pl)
AU (2) AU2002327690B2 (pl)
BR (3) BR0212716A (pl)
CA (3) CA2461071A1 (pl)
CO (3) CO5560590A2 (pl)
CY (1) CY1106398T1 (pl)
CZ (3) CZ2004361A3 (pl)
DE (3) DE60213108T2 (pl)
DK (2) DK1427732T3 (pl)
EG (2) EG24413A (pl)
ES (3) ES2282459T3 (pl)
HU (3) HUP0402378A3 (pl)
IL (3) IL160682A0 (pl)
MA (3) MA27064A1 (pl)
MX (3) MXPA04002569A (pl)
MY (2) MY129329A (pl)
NO (2) NO20041594L (pl)
NZ (3) NZ531123A (pl)
PE (3) PE20030474A1 (pl)
PL (3) PL370362A1 (pl)
PT (3) PT1427727E (pl)
RU (3) RU2278864C2 (pl)
SA (1) SA03230529B1 (pl)
SK (3) SK1502004A3 (pl)
WO (3) WO2003024973A1 (pl)
ZA (3) ZA200401260B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849627B2 (en) 2001-09-20 2005-02-01 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7087615B2 (en) 2001-09-20 2006-08-08 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia
US7473695B2 (en) * 2001-10-22 2009-01-06 Mitsubishi Tanabe Pharma Corporation 4-imidazolin-2-one compounds
US6677337B2 (en) * 2002-03-19 2004-01-13 The Procter & Gamble Company 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
PL379544A1 (pl) * 2002-09-09 2006-10-02 Amgen Inc. 1,4,5-podstawione pochodne 1,2-dihydro-pirazol-3-onu i 3-alkoksy 1H-pirazolu jako środki obniżające poziom TNF-alfa oraz interleukin do leczenia stanów zapalnych
WO2004087696A1 (de) * 2003-04-03 2004-10-14 Merck Patent Gmbh Pirazolidin-1,2-dicarbonsaüre-1-((phenyl)-amid)-2-((phenyl)-amid) derivate als koagulationsfaktor xa inhibitoren zur behandlung von thrombosen
GB0308466D0 (en) * 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US7482356B2 (en) * 2003-11-10 2009-01-27 The Procter & Gamble Company Bicyclic pyrazolone cytokine inhibitors
EP2012778A4 (en) * 2006-04-18 2011-08-10 Abbott Lab VANILLOID RECEPTOR (VR1) SUBType 1 ANTAGONISTS AND USES THEREOF
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
MX2011012343A (es) * 2009-05-19 2011-12-14 Dow Agrosciences Llc Compuestos y metodos para controlar hongos.
WO2016205284A1 (en) 2015-06-15 2016-12-22 Cummins Inc. Combustion chamber elasticity device
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods
CN107033090B (zh) * 2017-05-16 2019-05-07 无锡捷化医药科技有限公司 一种1,2,3,4-四氢噌啉的制备方法
RU2721684C1 (ru) * 2019-09-06 2020-05-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" Метил 2,3,8-триоксо-4-фенилтетрагидро-6Н-пиразоло[1,2-а]пирроло[2,3-c]пиразол-9а(1Н)-карбоксилаты
EP4422621A4 (en) * 2021-10-27 2025-08-27 Merck Sharp & Dohme Llc SPIROTRICYCLIC RIPK1 INHIBITORS AND METHODS OF USE THEREOF

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054291A (pl) 1963-02-26
GB1124982A (en) * 1965-02-09 1968-08-21 Lepetit Spa Diazabicyclo octanes and derivatives thereof
CH529153A (fr) 1969-10-27 1972-10-15 Lepetit Spa Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones
US5358924A (en) * 1991-03-21 1994-10-25 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrozoline derivatives, compositions and use
DK0640086T3 (da) * 1992-05-15 1999-12-06 Merrell Pharma Inc Mercaptoacetylamido-pyridazo[1,2-a][1,2]diazepin-derivateranvendelige som enkephalinase- og ACE-inhibitorer
GB9303993D0 (en) * 1993-02-26 1993-04-14 Fujisawa Pharmaceutical Co New heterocyclic derivatives
CN1272324C (zh) * 1999-09-07 2006-08-30 辛根塔参与股份公司 新颖的除草剂
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Also Published As

Publication number Publication date
NZ531122A (en) 2005-09-30
CN1250551C (zh) 2006-04-12
CN1257905C (zh) 2006-05-31
EP1427732A1 (en) 2004-06-16
MXPA04002570A (es) 2004-05-31
CN1556811A (zh) 2004-12-22
KR100656126B1 (ko) 2006-12-12
AU2002327690B2 (en) 2006-07-20
WO2003024970A1 (en) 2003-03-27
MA27066A1 (fr) 2004-12-20
JP2005504081A (ja) 2005-02-10
ZA200401260B (en) 2004-08-30
EP1427732B1 (en) 2006-07-12
EP1427727B1 (en) 2005-01-26
PT1427732E (pt) 2006-12-29
ATE287887T1 (de) 2005-02-15
EG24363A (en) 2009-03-04
BR0212716A (pt) 2004-08-03
SK1492004A3 (en) 2004-11-03
BR0212905A (pt) 2004-10-13
HUP0402500A2 (hu) 2005-03-29
KR100623879B1 (ko) 2006-09-19
ES2282459T3 (es) 2007-10-16
DK1427728T3 (da) 2007-07-09
CZ2004361A3 (cs) 2004-07-14
ES2268154T3 (es) 2007-03-16
PE20030474A1 (es) 2003-07-22
US6821971B2 (en) 2004-11-23
PT1427728E (pt) 2007-05-31
ZA200401403B (en) 2004-08-30
HUP0402378A2 (hu) 2005-02-28
KR20060036125A (ko) 2006-04-27
RU2004111805A (ru) 2005-04-10
RU2004111806A (ru) 2005-03-27
DE60218704T2 (de) 2007-11-08
SK1502004A3 (en) 2004-09-08
HUP0402500A3 (en) 2008-10-28
HK1071366A1 (en) 2005-07-15
IL160742A0 (en) 2004-08-31
EP1427727A1 (en) 2004-06-16
RU2299885C2 (ru) 2007-05-27
CN1555375A (zh) 2004-12-15
RU2272040C2 (ru) 2006-03-20
CY1106398T1 (el) 2011-10-12
KR20040035837A (ko) 2004-04-29
KR20040035836A (ko) 2004-04-29
AU2002334641B2 (en) 2007-03-29
ATE356126T1 (de) 2007-03-15
DK1427732T3 (da) 2006-10-30
CN1555379A (zh) 2004-12-15
DE60202782T2 (de) 2006-01-19
CA2461072A1 (en) 2003-03-27
AR037502A1 (es) 2004-11-17
CO5560590A2 (es) 2005-09-30
PL370362A1 (pl) 2005-05-16
AR037145A1 (es) 2004-10-27
NO20041594L (no) 2004-06-21
CO5560589A2 (es) 2005-09-30
ZA200401402B (en) 2004-08-27
CO5560579A2 (es) 2005-09-30
WO2003024973A1 (en) 2003-03-27
WO2003024971A1 (en) 2003-03-27
MA27064A1 (fr) 2004-12-20
NO20041605L (no) 2004-06-21
KR20040035835A (ko) 2004-04-29
BR0212673A (pt) 2004-08-24
US6566357B1 (en) 2003-05-20
SA03230529B1 (ar) 2008-06-21
DE60213108T2 (de) 2007-02-08
DE60213108D1 (de) 2006-08-24
DE60218704D1 (de) 2007-04-19
CZ2004358A3 (cs) 2004-07-14
HUP0402378A3 (en) 2008-10-28
PE20030430A1 (es) 2003-06-24
JP2005504083A (ja) 2005-02-10
RU2004111803A (ru) 2005-10-10
MY129329A (en) 2007-03-30
CA2461073A1 (en) 2003-03-27
EP1427728A1 (en) 2004-06-16
MY129069A (en) 2007-03-30
CZ2004345A3 (cs) 2004-06-16
JP2005504082A (ja) 2005-02-10
RU2278864C2 (ru) 2006-06-27
EG24413A (en) 2009-05-25
CA2461071A1 (en) 2003-03-27
MXPA04002574A (es) 2004-06-18
IL160682A0 (en) 2004-08-31
ES2237691T3 (es) 2005-08-01
AR037237A1 (es) 2004-11-03
CN1249066C (zh) 2006-04-05
MA27065A1 (fr) 2004-12-20
DE60202782D1 (de) 2005-03-03
US20030105084A1 (en) 2003-06-05
ATE332901T1 (de) 2006-08-15
NZ531063A (en) 2007-08-31
PT1427727E (pt) 2005-06-30
SK1482004A3 (en) 2004-08-03
PE20030446A1 (es) 2003-07-21
IL160741A0 (en) 2004-08-31
EP1427728B1 (en) 2007-03-07
PL370351A1 (pl) 2005-05-16
NZ531123A (en) 2006-08-31
HK1071565A1 (en) 2005-07-22
HUP0500752A2 (en) 2006-01-30
MXPA04002569A (es) 2004-05-31

Similar Documents

Publication Publication Date Title
PL370415A1 (pl) Związki hamujące wydzielanie cytokin zapalnych
WO2003045929A1 (en) Bicyclic derivative, process for producing the same, and use
NO20042584L (no) Dibenzylaminforbindelser og farmasoytisk anvendelse derav
AU2268302A (en) Inhibitors against the production and release of inflammatory cytokines
MXPA03010129A (es) N-aroilaminas-ciclicas.
GB0005357D0 (en) Compounds
GEP20074198B (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials
WO2005092858A3 (en) Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
CA2337825A1 (en) Disubstituted bicyclic heterocycles, the preparation thereof and their use as pharmaceutical compositions
EP1364950A4 (en) Pyridopyrimidine and naphthyridine derivatives
MY134226A (en) 1,2-dihydropyrazol-3-ones which control inflammatory cyctokines
NO20023298D0 (no) Nye imidazolderivater
NO20063111L (no) Fremgangsmate for fremstilling av tiazolpyrimidiner
IS7911A (is) Ímídasólafleiður með sækni í alfa 2 viðtakavirkni
CA2377233A1 (en) Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
EP1197211A4 (en) CANCER PREVENTION AND TREATMENT ACTIVE INGREDIENTS
TW200510300A (en) Amino alcohol compounds
SE0400440D0 (sv) Novel Cinnamic Amides
NO20041601L (no) Forbindelse som hemmer frigjøringen av inflammatoriske cytokiner
EP1197493A4 (en) benzimidazole
NO20062187L (no) Furanderivat som EP4-reseptorantagonister

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)